Overview

Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee

Status:
Unknown status
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
That Hylan G-F 20 may act to protect cartilage from the expected degree of degradation over a 12 month period in subjects with moderate to marked osteoarthritis of the knee
Phase:
Phase 4
Details
Lead Sponsor:
Cabrini Medical Centre
Collaborator:
Genzyme, a Sanofi Company
Treatments:
Hyaluronic Acid
Hylan